MapLight Therapeutics MPLT
NASDAQ MPLT
$7.70 +0.26 (+3.49%)
As of: Nov 11, 2026 · 11:45 AM EST

MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2024 - 2026)

Updated

MapLight Therapeutics' Net Equity Issued and Repurchased came in at $173,000 for Q4 2025, up 686.4% from $22,000 a year earlier and up 66.3% from the prior quarter.

Analysis

MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

For FY2025, MapLight Therapeutics' Net Equity Issued and Repurchased was $285,000, down 3.1% from FY2024.

  • Going back by year, Net Equity Issued and Repurchased was $294,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - 92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,000.00
Mar 31, 2026 651,000.00
Dec 31, 2025 173,000.00
Sep 30, 2025 104,000.00
Jun 30, 2025 3,000.00
Mar 31, 2025 5,000.00
Dec 31, 2024 22,000.00
API Access

MapLight Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MPLT&period=max&api_key=YOUR_API_KEY